Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hs6st1tm1Kkm mutation
(0 available);
any
Hs6st1 mutation
(26 available)
|
|
|
mortality/aging
|
• Background Sensitivity: mice die between E15.5 and prenatal stages with no mice being born on a BALB/c background
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hs6st1tm1Kkm mutation
(0 available);
any
Hs6st1 mutation
(26 available)
|
|
|
mortality/aging
|
• Background Sensitivity: mice die between E15.5 and prenatal stages with 7% of mice surviving into adulthood on a C3H/He background
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hs6st1tm1Kkm mutation
(0 available);
any
Hs6st1 mutation
(26 available)
|
|
|
Hs6st1tm1Kkm/Hs6st1tm1Kkm mice exhibit growth retardation and abnormal eye, phalanges, and tarsus morphology
mortality/aging
|
• Background Sensitivity: mice die between E15.5 and prenatal stages with 4% of mice surviving into adulthood on a C57BL/6 background
|
embryo
|
• fewer red blood cells are found in the placenta
• placenta angiogenesis is disrupted
• 60% fewer microvessels are present compared to in wild-type mice
|
skeleton
|
• hind limb phalanges are missing
|
|
• hind limb tarsus is either smaller or missing
|
|
• morphogenesis is retarded in the limb skeleton
|
respiratory system
|
• mice exhibit alveolar enlargement that is more pronounced in adult mice
|
vision/eye
|
• half of mice have abnormal eye morphology
|
growth/size/body
limbs/digits/tail
|
• hind limb phalanges are missing
|
|
• hind limb tarsus is either smaller or missing
|
cardiovascular system
|
• fewer red blood cells are found in the placenta
• placenta angiogenesis is disrupted
• 60% fewer microvessels are present compared to in wild-type mice
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hs6st1tm1Kkm mutation
(0 available);
any
Hs6st1 mutation
(26 available)
Hs6st2tm1.1Kkm mutation
(1 available);
any
Hs6st2 mutation
(9 available)
|
|
|
cellular
|
• decrease in FGF1-, FGF2-, and FGF3-induced cell proliferation in double homozygous MEFs
|